Alina S Bergshoeff
Radboud University Nijmegen(NL)Radboud University Medical Center(NL)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV-related health complications and treatments, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Pharmacokinetics and 24-Week Efficacy/Safety of Dual Boosted Saquinavir/Lopinavir/Ritonavir in Nucleoside-Pretreated Children(2005)51 cited
- → Plasma Pharmacokinetics of Once- versus Twice-Daily Lamivudine and Abacavir: Simplification of Combination Treatment in HIV-1-Infected Children (Penta-13)(2005)46 cited
- Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13).(2005)
- → Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children(2002)42 cited
- → Pharmacokinetics of Nelfinavir in Children: Influencing Factors and dose Implications(2003)37 cited
- → Nelfinavir Plasma Concentrations Are Low during Pregnancy(2004)37 cited
- → Plasma Concentrations of the HIV-Protease Inhibitor Lopinavir are Suboptimal in Children Aged 2 Years and Below(2007)37 cited
- → Age-dependent Pharmacokinetics of Lamivudine in HIV-infected Children(2007)30 cited
- → Increased Dose of Lopinavir/Ritonavir Compensates for Efavirenz-Induced Drug-Drug Interaction in HIV-1-Infected Children(2005)29 cited
- → Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1–infected children(2004)25 cited